JP2022502501A5 - - Google Patents

Info

Publication number
JP2022502501A5
JP2022502501A5 JP2021540398A JP2021540398A JP2022502501A5 JP 2022502501 A5 JP2022502501 A5 JP 2022502501A5 JP 2021540398 A JP2021540398 A JP 2021540398A JP 2021540398 A JP2021540398 A JP 2021540398A JP 2022502501 A5 JP2022502501 A5 JP 2022502501A5
Authority
JP
Japan
Prior art keywords
alkyl
substituted
formula
phenyl
methyl
Prior art date
Application number
JP2021540398A
Other languages
English (en)
Japanese (ja)
Other versions
JPWO2020069043A5 (https=
JP2022502501A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2019/053032 external-priority patent/WO2020069043A1/en
Publication of JP2022502501A publication Critical patent/JP2022502501A/ja
Publication of JPWO2020069043A5 publication Critical patent/JPWO2020069043A5/ja
Publication of JP2022502501A5 publication Critical patent/JP2022502501A5/ja
Priority to JP2024082290A priority Critical patent/JP2024109735A/ja
Pending legal-status Critical Current

Links

JP2021540398A 2018-09-25 2019-09-25 新規使用 Pending JP2022502501A (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2024082290A JP2024109735A (ja) 2018-09-25 2024-05-21 新規使用

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201862736324P 2018-09-25 2018-09-25
US62/736,324 2018-09-25
PCT/US2019/053032 WO2020069043A1 (en) 2018-09-25 2019-09-25 Novel uses

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2024082290A Division JP2024109735A (ja) 2018-09-25 2024-05-21 新規使用

Publications (3)

Publication Number Publication Date
JP2022502501A JP2022502501A (ja) 2022-01-11
JPWO2020069043A5 JPWO2020069043A5 (https=) 2022-10-04
JP2022502501A5 true JP2022502501A5 (https=) 2022-10-04

Family

ID=69953335

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2021540398A Pending JP2022502501A (ja) 2018-09-25 2019-09-25 新規使用
JP2024082290A Pending JP2024109735A (ja) 2018-09-25 2024-05-21 新規使用

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2024082290A Pending JP2024109735A (ja) 2018-09-25 2024-05-21 新規使用

Country Status (4)

Country Link
US (1) US20210338679A1 (https=)
EP (1) EP3856191A4 (https=)
JP (2) JP2022502501A (https=)
WO (1) WO2020069043A1 (https=)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US12396992B2 (en) 2019-01-07 2025-08-26 Intra-Cellular Therapies, Inc. Organic compounds
AU2020343329C1 (en) 2019-09-03 2026-02-12 Intra-Cellular Therapies, Inc. Methods of treatment
WO2021127517A1 (en) * 2019-12-18 2021-06-24 Intra-Cellular Therapies, Inc. Novel uses
US12364695B2 (en) 2020-06-02 2025-07-22 Intra-Cellular Therapies, Inc. Methods of treating inflammatory disease
WO2025212780A1 (en) * 2024-04-02 2025-10-09 Intra-Cellular Therapies, Inc. Organic compounds

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8273750B2 (en) 2005-06-06 2012-09-25 Takeda Pharmaceutical Company Limited Organic compounds
JP5453086B2 (ja) 2006-06-06 2014-03-26 イントラ−セルラー・セラピーズ・インコーポレイテッド 有機化合物
ES2588238T3 (es) 2007-12-06 2016-10-31 Intra-Cellular Therapies, Inc. Derivados de pirazolopirimidin-4,6-diona y su uso como producto farmacéutico
AU2008335811B2 (en) 2007-12-06 2012-05-17 Intra-Cellular Therapies, Inc. Organic compounds
JP5989993B2 (ja) 2008-12-06 2016-09-07 イントラ−セルラー・セラピーズ・インコーポレイテッドIntra−Cellular Therapies, Inc. 有機化合物
WO2010065147A1 (en) 2008-12-06 2010-06-10 Intra-Cellular Therapies, Inc. Organic compounds
AU2009322904A1 (en) 2008-12-06 2010-06-10 Intra-Cellular Therapies, Inc. Organic compounds
KR20110098732A (ko) 2008-12-06 2011-09-01 인트라-셀룰라 써래피스, 인코퍼레이티드. 유기 화합물
CN102231953A (zh) 2008-12-06 2011-11-02 细胞内治疗公司 有机化合物
EP2560676B8 (en) 2010-04-22 2016-10-12 Intra-Cellular Therapies, Inc. Organic compounds
TW201206937A (en) 2010-05-31 2012-02-16 Intra Cellular Therapies Inc Organic compounds
WO2011153135A1 (en) 2010-05-31 2011-12-08 Intra-Cellular Therapies, Inc. Organic compounds
US9434730B2 (en) 2010-05-31 2016-09-06 Intra-Cellular Therapies, Inc. PDE1 inhibitor compounds
US9763948B2 (en) 2010-05-31 2017-09-19 Intra-Cellular Therapies, Inc. PDE1 inhibitory compounds and methods
US10695431B2 (en) * 2010-10-29 2020-06-30 Infirst Healthcare Limited Solid solution compositions and use in cardiovascular disease
US9308213B2 (en) * 2010-10-29 2016-04-12 Infirst Healthcare Limited Solid solution compositions and use in chronic inflammation
WO2013138118A1 (en) * 2012-03-14 2013-09-19 The Regents Of The University Of California Treatment of inflammatory disorders in non-human mammals
CA2906640C (en) 2013-03-15 2021-07-20 Intra-Cellular Therapies, Inc. Substituted imidazo-[1,2-a]pyrazolo[4.3-e]pyrimidin-4[5h]-one compounds and pharmaceutical compositions and use therof as pde1 inhibitors
WO2018049417A1 (en) 2016-09-12 2018-03-15 Intra-Cellular Therapies, Inc. Novel uses

Similar Documents

Publication Publication Date Title
JP2022502501A5 (https=)
JP2019531320A5 (https=)
RU2001111875A (ru) Омепразол формы А, способ его получения, фармацевтиченский препарат на его основе и способ лечения желудочно-кишечных расстройств
CN109316601B (zh) 药物组合物及其用途
JP2007533722A5 (https=)
RU2002107203A (ru) Производные N-гетероциклических соединений в качестве ингибиторов синтазы оксида азота (nos)
US6211233B1 (en) Prostaglandin pharmaceutical compositions
JP2010520307A5 (https=)
RU2001119990A (ru) Применение антагониста AT-1 или модулятора рецептора АТ-2 для лечения болезней, связанных с увеличением содержания рецепторов АТ-1 или АТ-2
JP2010522710A5 (https=)
JP2019535761A5 (https=)
JPH039900B2 (https=)
JP2007508386A5 (https=)
BRPI0415873A (pt) métodos de uso de antagonistas do receptor de trombina
JP2008512426A5 (https=)
RU2005106356A (ru) Новое соединение
JP2006504738A5 (https=)
RU2005106355A (ru) Новое соединение
JPWO2020069043A5 (https=)
JP2004532894A5 (https=)
JP2022502501A (ja) 新規使用
JP2010504321A5 (https=)
JP2553170B2 (ja) 置換ジカルボン酸−ビス(3,5,−ジカルバモイル−2,4,6,−トリヨード−アニリド)、その製法およびこの化合物を含有するレントゲン造影剤
IL310383A (en) DP antagonist
JP2021520394A5 (https=)